Agilent Technologies introduces new fluorescent in situ hybridization assays for molecular analysis

Agilent Technologies today introduced Agilent SureFISH probes, their next generation of fluorescent in situ hybridization (FISH) assays, delivering a comprehensive menu of high resolution probes for a wide range of molecular analysis applications. Agilent SureFISH probes deliver higher performance compared to existing FISH products. SureFISH probes enable users to specifically detect aberrations in regions of the genome as small as 50kb, as well as aberrations near highly repetitive regions. They are designed to enable users to meet American College of Medical Genetics guidelines for clinical cytogenetics. "Based on our experience with Agilent high-resolution oligo FISH, it is apparent the oligo design methodology for SureFISH will be a powerful tool for analysis of previously difficult genomic regions," said early access user Shashikant Kulkarni, M.S., Ph.D., FACMG, head of Clinical Genomics and medical director, Cytogenomics and Molecular Pathology, Washington University School of Medicine at St. Louis.